$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Stock Runner: Bionano Genomics, Inc. (NASDAQ:BNGO), New York Community Bancorp, Inc. (NYSE:NYCB)
12:04am, Friday, 17'th Dec 2021 Stock Equity
Bionano Genomics, Inc. (NASDAQ:BNGO) with the stream of -3.80% also noticed, India New York Community Bancorp, Inc. (NYSE:NYCB) encountered a rapid change of 1.11% in the last hour of Thursdays The post Stock Runner: Bionano Genomics, Inc. (NASDAQ:BNGO), New York Community Bancorp, Inc. (NYSE:NYCB) appeared first on Stocks Equity .
During The Past Six Months, Bionano Genomics Inc. (NASDAQ: BNGO) Shares Took An -56.49% Jump. Here Is What We Should Expect
01:00pm, Thursday, 16'th Dec 2021 Marketing Sentinel
During the last session, Bionano Genomics Inc. (NASDAQ:BNGO)s traded shares were 7.04 million. At the end of the trading day, the stocks price was $3.42, reflecting an intraday gain of 4.91% or $0.16. The 52-week high for the BNGO share is $15.69, that puts it down -358.77 from that peak though still a striking 85.67% During The Past Six Months, Bionano Genomics Inc. (NASDAQ: BNGO) Shares Took An -56.49% Jump. Here Is What We Should Expect Read More »
Bionano Genomics Inc (BNGO): Price Now Near $3.26; Daily Chart Shows Downtrend on 20 Day Basis
03:19pm, Wednesday, 15'th Dec 2021 ETF Daily News
This is a reversal of the price action on the previous hour, in which price moved down. The post Bionano Genomics Inc (BNGO): Price Now Near $3.26; Daily Chart Shows Downtrend on 20 Day Basis appeared first on ETF Daily News .
Sharp Percentage Decline Stock: Bionano Genomics, Inc. (NASDAQ:BNGO), PG&E Corporation (NYSE:PCG)
11:21pm, Tuesday, 14'th Dec 2021 Stock Equity
Bionano Genomics, Inc. (NASDAQ:BNGO) with the stream of -2.10% also noticed, India PG&E Corporation (NYSE:PCG) encountered a rapid change of -0.90% in the last hour of Tuesdays trading session. Bionano The post Sharp Percentage Decline Stock: Bionano Genomics, Inc. (NASDAQ:BNGO), PG&E Corporation (NYSE:PCG) appeared first on Stocks Equity .
This Analyst's Saphyr Calculations Suggest Buying Bionano While It's Down
10:35am, Tuesday, 14'th Dec 2021
If BNGO stock reaches Oppenheimer's price target, investors are looking at a return of more than 300%, plus long-term growth potential. The post This Analyst's Saphyr Calculations Suggest Buying Biona
Oppenheimer Pounds the Table on Bionano Stock
03:34pm, Friday, 10'th Dec 2021 TipRanksOn Wednesday, Bionano Genomics (BNGO) informed investors that authors at The University of Texas MD Anderson Cancer Center have published a study util
Do Options Traders Know Something About Bionano (BNGO) Stock We Don't?
09:59am, Friday, 10'th Dec 2021
Investors need to pay close attention to Bionano (BNGO) stock based on the movements in the options market lately.
Bionano Genomics Inc. (NASDAQ: BNGO) Spiked 0.81% In 6 Months Getting Ready For Whats Next
02:00pm, Thursday, 09'th Dec 2021 Marketing Sentinel
Bionano Genomics Inc. (NASDAQ:BNGO)s traded shares stood at 7.87 million during the last session. At the close of trading, the stocks price was $3.73, to imply an increase of 3.04% or $0.11 in intraday trading. The BNGO shares 52-week high remains $15.69, putting it -320.64% down since that peak but still an impressive 86.86% since Bionano Genomics Inc. (NASDAQ: BNGO) Spiked 0.81% In 6 Months Getting Ready For Whats Next Read More »
Bionano Genomics Announces 2022 Symposium Featuring Four Consecutive Days of OGM Presentations and Live Panel Discussions Delivered by 25 Different Customers Across a Wide Range of Genetic Disease and Cancer Applications
01:00pm, Thursday, 09'th Dec 2021 Intrado Digital Media
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr ® system and the leading software for genomic data visualization, interpretation and reporting, today announced its 2022 Symposium featuring four consecutive days of OGM presentations delivered by 25 different customers worldwide across a wide range of genetic diseases and cancer applications. The Symposium will take place virtually from January 10 to 13, 2022. During these four days, customers will showcase their latest research findings using OGM in constitutional cytogenomics, hematologic malignancies, solid tumors, and in combination with next-generation sequencing (NGS). Each day will feature oral customer presentations, a live panel with Q&A and a scientific poster exhibit within the virtual exhibition hall.
Bionano Genomics, Inc. (NASDAQ:BNGO) Receives $11.00 Consensus PT from Brokerages
07:32pm, Monday, 06'th Dec 2021 Transcript Daily
Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) have been given a consensus rating of Buy by the four ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and three have given a buy rating to the company. The average 12 month target price among []
Heres What to Focus on: Bionano Genomics, Inc. (NASDAQ:BNGO), Kinder Morgan, Inc. (NYSE:KMI)
07:38am, Monday, 06'th Dec 2021 Stock Equity
Bionano Genomics, Inc. (BNGO) with the stream of -8.36% also noticed, India Kinder Morgan, Inc. (KMI) encountered a rapid change of -0.89% in the last hour of trading session. Bionano The post Heres What to Focus on: Bionano Genomics, Inc. (NASDAQ:BNGO), Kinder Morgan, Inc. (NYSE:KMI) appeared first on Stocks Equity .
Glistening Stocks Review: Bionano Genomics, Inc. (NASDAQ:BNGO), Marathon Petroleum Corporation (NYSE:MPC)
09:28am, Saturday, 04'th Dec 2021 Stock Equity
Bionano Genomics, Inc. (BNGO) with the stream of -8.36% also noticed, India Marathon Petroleum Corporation (MPC) encountered a rapid change of -2.62% in the last hour of Fridays trading session. The post Glistening Stocks Review: Bionano Genomics, Inc. (NASDAQ:BNGO), Marathon Petroleum Corporation (NYSE:MPC) appeared first on Stocks Equity .
Bionano Genomics, Inc. (NASDAQ:BNGO) CEO Purchases $20,049.75 in Stock
02:12pm, Thursday, 02'nd Dec 2021 Dakota Financial News
Bionano Genomics, Inc. (NASDAQ:BNGO) CEO R. Erik Holmlin acquired 5,025 shares of the businesss stock in a transaction on Monday, November 29th. The shares were purchased at an average price of $3.99 per share, for a total transaction of $20,049.75. The acquisition was disclosed in a document filed with the SEC, which is available through []
Bionano Genomics, Inc. (NASDAQ:BNGO) Receives Average Rating of Hold from Analysts
12:56pm, Wednesday, 01'st Dec 2021 Dakota Financial News
Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) have earned an average recommendation of Hold from the five ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. The average []
Bionano Genomics Proves Not Everything Genetic is Gold
06:00am, Wednesday, 01'st Dec 2021
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.
Sign In
Buy BNGO